Member Info for JRDC

Both website and app are showing my avacta portfolio as now being worth £0. Wouldn't surprise me so didn't think much of it, but its also showing nova, AMD and syma as £0 which obv aint right.

Anyone else unfortunate to use II as their sipp platform and is yours showing the same?

Thats only if they get the contracts though arnold. Novacyt, which is the only comparison I can make, on course for likely revenues of between £400m and £800m depending on phase 2 from Feb 2020 to Feb 2021 and other sales that have been made but figures not public, and thats with a current £642m mcap (won't know exact numbers until July). Granted SP would have been over £15 now before pfizer torpedoed covid stocks. So applying same logic to avacta, lets assume bams, lft news pushed SP to dizzying heights of £2.50, anything less than £600m in contracts could see it tumbling down imo, which is what happened to nova in May. I don't know what LFT manufacturing capacity is, but lets say 10m a month, lft £10 a test, its a minimum of 6 months from approval to create £600m worth of products. Other issue is nova designed, manufactured and distributed the majority themselves, few 3rd parties taking a cut and they've confirmed 60% profit margin. Avacta's could be half that, then that probably means £900m+ in contracts / sales from bams, lft etc required based on covid stock logic demonstrated with nova. Might seem pessimistic but then the numbers nova are making are astronomical compared to 12 months back and their SP went under £7 recently. Yes, avacta has fingers in other pies, but ava hasn't even been announced yet, and I'm not expecting revenues from that for years. So yeah, if price does shoot up when the RNS of our dreams lands, don't expect it to stay there for long

Al said June, which I presume now meant 2021. Anything before then is a bonus. He's either a complete chancer who doesn't care about investers, what with the placing, selling a huge chunk of his holding shortly before the crash, the switch to swabs, vague jam RNSs, or he's an idiot who shouldn't be allowed a crayon, let alone run a company. I've not decided which is worse.... And I speak as someone near £30k down and fed up, so if my opinion hurts your feelings of Saint Al, tough tits.

GM at Novacyt had a quiet spell for good reason, he was signing hundreds of millions pound worth of contracts, not down DFS in the crunch period picking out a new sofa.

Boris will be slated whichever way. He's allowed 3 families to meet, but in the same breath asked families not to meet up, knowing that those who don't give a **** will meet up regardless if lock down continued . Sensible families like mine have decided not to meet with parents until safe to do so when they've both received the vaccine. It's not his fault approx 1/3 of the population are selfish morons. If covid only affected this 1/3 then that would be fine, but it doesnt

Could be worse Baba, you could be heavily invested in Avacta like me. All we know for 100% fact this year is the director has a new house. Absolutely appalling communication from them, we're about the only covid stock not to have any products to sell.

The first paragraph he says mutations may cause the jab to be ineffective. The 2nd paragraph he says people who say it will make the jab ineffective are talking bolox.

He should be a politician.

Tbf Stanley, you are a complete nob and do talk some bolox. Trying to wind up the nova guys is like us arsenal fans taking the **** out of Tottenham at the moment

Prop5 - I knew that would happen when I sold half of my holding there last week and bought in to Avacta hoping for a Monday RNS. Serves me right haha.
2nd phase of the contract looks like a shoe in, happy for you guys. Hoping we'll get our 100% increase early next year. Innova are doing a great job of destroying the reputation of LFT's though

Contract extension is pretty much guaranteed now. Surescreen won't be able to ramp up production as much, and their tests still need confirming by PCR. No one else has a test yet.

The conspiracy theorist in me says that xiamen have offered to pay for Al's conservatory if they delay releasing avactas test until their contract is sorted for 6 months.

Would be daft to sell now, if contract extended / phase 2 thats easily £12 smashed (and is looking hugely likely given innova's rep has been destroyed, and avacta still haven't even got a test of any kinds). If contract not renewed then at worst imo a drop back to £7 until we get our sales news next year, which if still £20-30m a month, we're back at £12...

https://www.bbc.co.uk/news/health-55188183

https://www.bbc.co.uk/news/health-55188183

Was this innova? Will it give all LFT a bad rep or do you think it just helps our case?

I'm in Avacta, far more so than nova right now, and I'd love the worry that we might only make £300m from UK govt alone this year.

It's embarrassing that a vaccine - something that should take 10 years - has been designed, created and soon to be approved before Al gets our test to market. Tried to be clever and go for saliva and backfired. Still hoping to double my money there, but not a shoe-in like it seemed back in August.

The article, combined with vaccine approval could well send the SP down to daft levels as holders panic, we'll probably have more cash in the bank than the mcap. Feel a bit for those who went in at £10+. If this does reach levels not seen since sept I'll be chucking more in, could end up as being a bargain if anything like £5 is hit, before a nice bounce mid morning

Article isn't that bad, nova and govt knew that training would be needed - that's part of the contract.

ODX released an RNS when they had their bad news and it made things worse, hoping nova keeps quiet for now.

Surescreen didn't get involved with condor or whatever the govt scheme was. They sent their antibody tests in for approval back in march and the Govt just sat in them which ****ed them off - Al can sympathise. Think they did what Avacta have done and worked with a university to get validation back in early sept (think Tom there mentioned Birmingham - don't blame them for not using Derby ha). They target their antibody tests abroad, I imagine they'll be doing the same with the antigen. So I don't really see them as a competitor, they entered a different race

£15 + vat a test for the less accurate visual one, business to business sales only, min order 25 units, lead time is around 3-4 weeks. Their literature recommends that positive test results get confirmation by PCR. Im placing an order if they can guarantee delivery before Xmas, so myself and other colleagues can test ourselves before we see family at Xmas, will let you know how good they are. Imagine if Avacta had managed to get self use approval, most of the country could have bought a £10 test and performed it before Xmas gatherings. Hopefully they'll have something for Easter.

Price will hit £6 when vaccines are given approval in early dec, people selling who have no clue that testing is still required. Govt is looking for LFT for general use which is why avactas is one of the few to rise today. Some updated sales figures would be nice, esp with france and US market. If we're bringing in 1m euros per hospital, germany are one of our biggest customers, it could be hundreds of smaller orders, all amounting to £100m+. Bojo is saying relatives can visit care homes next year, so it looks like NCYT and the portable intruments will be used there, we need antibody news which at the moment is none exisistant - again I imagine this will go hand in hand with vaccines for next 5+ years. Numbers are what we need, all we know is we have roughly £350m in revenue, minimum, so far this year

I think when vaccines are approved in next few weeks we'll see 90p, maybe less based on recent form, will be a great time to buy as when BAMS and LFD swab test approved in early 21 I reckon it will then double. This time next year we'll have had early indications from clinical cancer trials which will be far bigger news than anything covid related. I couldn't even make an educated guess at what the SP will be in 12 months time, will be a heck of lot more than 90p.

I'm guessing mfm lumped in when it hit £1, don't blame him, and now jumped on the ramp train. Better late than never, welcome aboard. Next stop, £1.50 close tomorrow. Choo Choo